Exchange Traded Concepts LLC Lowers Stock Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Exchange Traded Concepts LLC cut its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report) by 3.0% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 86,109 shares of the pharmacy operator’s stock after selling 2,664 shares during the period. Exchange Traded Concepts LLC’s holdings in Walgreens Boots Alliance were worth $803,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. Brooklyn Investment Group lifted its holdings in Walgreens Boots Alliance by 21.1% during the fourth quarter. Brooklyn Investment Group now owns 4,757 shares of the pharmacy operator’s stock valued at $44,000 after purchasing an additional 830 shares in the last quarter. First Financial Corp IN lifted its holdings in Walgreens Boots Alliance by 49.2% during the fourth quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock valued at $25,000 after purchasing an additional 885 shares in the last quarter. Sequoia Financial Advisors LLC lifted its holdings in Walgreens Boots Alliance by 4.4% during the third quarter. Sequoia Financial Advisors LLC now owns 25,215 shares of the pharmacy operator’s stock valued at $226,000 after purchasing an additional 1,063 shares in the last quarter. Lincluden Management Ltd. lifted its holdings in Walgreens Boots Alliance by 0.4% during the third quarter. Lincluden Management Ltd. now owns 264,644 shares of the pharmacy operator’s stock valued at $2,371,000 after purchasing an additional 1,074 shares in the last quarter. Finally, CWA Asset Management Group LLC lifted its holdings in Walgreens Boots Alliance by 9.2% during the fourth quarter. CWA Asset Management Group LLC now owns 12,893 shares of the pharmacy operator’s stock valued at $120,000 after purchasing an additional 1,084 shares in the last quarter. 58.59% of the stock is owned by hedge funds and other institutional investors.

Walgreens Boots Alliance Price Performance

Shares of WBA opened at $11.25 on Thursday. Walgreens Boots Alliance, Inc. has a 1-year low of $8.08 and a 1-year high of $23.76. The stock has a market cap of $9.72 billion, a PE ratio of -1.10, a P/E/G ratio of 1.46 and a beta of 0.64. The firm has a 50-day simple moving average of $9.96 and a two-hundred day simple moving average of $9.86. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.64 and a quick ratio of 0.30.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last announced its quarterly earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, beating analysts’ consensus estimates of $0.38 by $0.13. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The business had revenue of $39.50 billion during the quarter, compared to analysts’ expectations of $37.40 billion. During the same period last year, the business earned $0.66 earnings per share. The business’s revenue for the quarter was up 7.6% on a year-over-year basis. As a group, analysts forecast that Walgreens Boots Alliance, Inc. will post 1.59 EPS for the current year.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on WBA shares. TD Cowen decreased their price objective on shares of Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating on the stock in a report on Tuesday, October 22nd. Bank of America raised their price target on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an “underperform” rating in a research note on Monday, January 13th. UBS Group raised their price target on shares of Walgreens Boots Alliance from $9.00 to $10.00 and gave the stock a “neutral” rating in a research note on Thursday, October 17th. Morgan Stanley decreased their price target on shares of Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating on the stock in a research note on Friday, October 11th. Finally, Barclays raised their price target on shares of Walgreens Boots Alliance from $7.00 to $8.00 and gave the stock an “underweight” rating in a research note on Wednesday, October 16th. Four investment analysts have rated the stock with a sell rating, nine have issued a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $13.27.

View Our Latest Stock Report on WBA

Walgreens Boots Alliance Profile

(Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Further Reading

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.